Logo for Imunon Inc

Imunon Investor Relations Material

Latest events

Logo for Imunon Inc

Q4 2023

Imunon
Logo for Imunon

Q4 2023

28 Mar, 2024
Logo for Imunon

Q3 2023

14 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Imunon Inc

Access all reports
Imunon Inc., formerly Celsion Corporation, a clinical stage biotechnology company, focuses on the development of novel theragnostic technologies for cancer, including the use of radiolabeled DNA plasmids to treat cancer. Celsion has developed, among other, ThermoDox, a DNA plasmid with its proprietary heat-activated liposomal delivery technology, which is designed to improve the effectiveness of cancer immunotherapies such as vaccines and adoptive cell therapies. The company's customers are pharmaceutical and biotechnology companies, research institutions, hospitals and clinics.